THE CORRELATION BETWEEN THE CONCENTRATIONS OF CERTAIN CYTOKINES, ANTIBODIES, AND RHEUMATOID ARTHRITIS DISEASE ACTIVITY

Văn Ái Lưu

Main Article Content

Abstract

Background: Serum cytokine levels and their relationship to the disease activity of rheumatoid arthritis  have become the subject of numerous studies worldwide. However, data on this issue remain scarce in Vietnam. Objectives: The study aim to evaluate the correlation between the concentrations of certain cytokines and the VAS and DAS28 scale in patients with rheumatoid arthritis. Materials and methods: A cross-sectional descriptive study was conducted on 62 patients diagnosed and treated for rheumatoid arthritis at the Department of Rheumatology, Cho Ray Hospital, from April 2023 to January 2024. Results: The research population had a mean age of 56.7 ± 9.8 years, with a male-to-female ratio of approximately 1:4. The results indicated that the levels of the surveyed cytokines and antibodies were elevated. The average VAS, DAS28, and concentration of CRP were 36.71 ± 16.12, 7.17 ± 0.89, and 63.28 ± 60.48 mg/L, respectively, reflecting moderate to high disease activity in rheumatoid arthritis. Spearman correlation analysis showed that IL-1α, IL-4, VEGF, IFN-γ, TNF-α, and RF had positive correlations with the DAS28 score (p < 0.05). Among these, IL-1α, IL-4, and IFN-γ exhibited moderate correlations (r: 0.378; 0.309, and 0.308), while VEGF, TNF-α, and RF showed weak correlations (r: 0.243; 0.268, and 0.236). Regarding the VAS score, only IL-1α, IL-4, and IFN-γ demonstrated moderate positive correlations (r: 0.331; 0.314, and 0.300; p < 0.01). Conclusion: The key findings of this study suggest that, in the context of moderate to high disease activity, several cytokine markers, including IL-1α, IL-4, and IFN-γ, have significant positive correlations with both the VAS and DAS28. Additionally, VEGF, TNF-α, and RF also exhibit weak correlations with the DAS28.

Article Details

References

1. Aletaha D., Neogi T., Silman A.J., et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569-2581.
2. Alunno A., Carubbi F., Giacomelli R., Gerli R. Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol. 2017; 1:3.
3. Burska A., Boissinot M., Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014; 2014:545493.
4. Dissanayake K,. Jayasinghe C., Wanigasekara P., Sominanda A. Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A. PLoS One. 2021; 16(1):e0246111.
5. Koper-Lenkiewicz O.M., Gińdzieńska-Sieśkiewicz E., Kamińska J., et al. Could IL-1β, IL-6, IFN-γ, and sP-selectin serum levels be considered as objective and quantifiable markers of rheumatoid arthritis severity and activity? Reumatologia. 2022; 60(1):16-25.
6. Li B., Guo Q., Wang Y., et al. Increased serum interleukin-2 levels are associated with abnormal peripheral blood natural killer cell levels in patients with active rheumatoid arthritis. Mediators Inflamm. 2020; 2020:6108342.
7. Meyer P.W., Hodkinson B., Ally M., et al. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm. 2010; 2010:158514.
8. Osiri M., Wongpiyabovorn J., Sattayasomboon Y., Thammacharoenrach N. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics. Clin Rheumatol. 2016; 35(7):1673-1681.
9. Sokolova M.V., Schett G., Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol. 2022; 63(2):138-151.